Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Perdpmaldoed medicines/vaccines /drugs are becoming more amd lore sought after which should help PYC
https://www.bbc.co.uk/news/health-68897731
An important trial of the world's first "personalised" mRNA vaccine against the deadliest form of skin cancer - melanoma - is now under way in the UK.
Steve Young, 52, from Stevenage, Herts, who had a melanoma growth cut out of his scalp last August, is one of the first patients to try the shot.
It is designed to help his immune system recognise and wipe out any remaining cancerous cells.
And hopefully, that means his cancer will not return.
The jab, mRNA-4157 (V940), uses the same technology as current Covid vaccines and is being tested in final-stage Phase III trials.
University College London Hospitals (UCLH) doctors are giving it alongside another drug, pembrolizumab or Keytruda, that also helps the immune system kill cancer cells.
Genetic signature
The combined treatment, made by Moderna and Merck Sharp and Dohme (MSD), is not yet available routinely on the NHS, outside of clinical trials.
Experts in some other countries, including Australia, are also trying it on patients, to gather more evidence and see whether it should be rolled out more widely.
The vaccine is personalised - meaning the make-up of it is changed to suit the individual patient.
Because
For about 7 -10 day s you can only buy £2,000 or so and then once bought it often goes to negotiates trade to buy , this is counter intuitive for a marker maker who wants to make a "market "
So now it's moved to 1.6p ask price it will soon be hard to buy after 1 or 2 buys
The DDR therapeutics market was estimated to be valued at US$5.9 billion in 2022 and is projected to reach US$10.4 billion by 2031 with a CAGR of 6.5%1. This is expected to be driven by an increase in the use of combination therapy for the treatment of drug-resistant cancers and the need for novel targeted medicines for cancer treatment. Most cancers rely on the DDR pathway to a greater extent than healthy cells.
Thanks NK
Pyc are at the forefront of huge change in drug approval amd testing using A.I and mathematics
They ar e due to hit £900k+revenues and a pipeline of £1.6mln (up 60% in 4mths )
PYC current valuation is ludicrous